Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New option for patients with lipid disorders introduced in U.S.

Sep. 17, 2003

Roche and Vernalis present novel 5-HT2C agonists for obesity and other uses

Sep. 17, 2003

Novel LXR modulators discovered by Tularik team

Sep. 17, 2003

BMS and QDose collaborate on inhaled insulin product development

Sep. 16, 2003

Novel GSK-3 inhibitors, their preparation and use claimed by GSK scientists

Sep. 16, 2003

Good pharmacokinetic and safety profile reported for the new antidiabetic drug tesaglitazar

Sep. 16, 2003

Thyroid hormone receptor beta agonists: novel class of agents for lipoprotein disorders and obesity

Sep. 16, 2003

Genzyme expands access to Myozyme

Sep. 15, 2003

Regeneron to advance phase III Axokine program in obesity

Sep. 15, 2003

Potent antagonist of human glucagon receptor presented at ACS meeting

Sep. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...